U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524959) titled 'Antagonism of Neostigmine in Continuous Infusion of Mivacurium' on March 28.
Brief Summary: In this study, the antagonism of neostigmine, a cholinesterase inhibitor, on continuous infusion of mivacurium during foot and ankle surgery under general anesthesia was investigated, and the appropriate time point of antagonism was explored.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Neuromuscular Blocking Agents
Intervention:
DRUG: Neostigmine
Administer neostigmine at a dose of 0.04 mg/kg (combined with 0.02 mg/kg atropine)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Beijing Tongren Hospital
Disclaimer: C...